Have you had an Abnormal Pap Smear in the Last 18 months?
The World Health Organization in 2022 reports cervical cancer is the fourth most common cancer in women, resulting in approximately 350,000 deaths globally. Cervical cancer is almost entirely preventable with certain precautions taken. Routine testing for abnormal cells through a pap smear is one of the best ways to screen for cervical cancer. When abnormal cells appear on a test, proper and early treatment can avoid the development of cervical cancer.
Abnormal cells are classified on a 3-scale severity of abnormality. CIN-3 (cervical intraepithelial neoplasia) is the most severe, and prompt treatment is recommended. CIN-2 and CIN-1 are moderate and mild cases, which are sometimes treated, but more often cautiously observed and followed up to determine if treatment is necessary. This period is an opportune time to intervene and promote the regression of abnormal cell growth. Removal of abnormal cells currently involves ablation and/or excision of cells which are invasive and very uncomfortable for patients, with up to 6 weeks of recovery. Less invasive treatments are warranted with fewer side effects.
Papillex is a dietary supplement containing vitamins A, B12, C, and E, folate, zinc, selenium, green tea leaf extract, broccoli sprout powder, astragalus, natural all-trans-lycopene and Reishi mushroom extracts. These ingredients have been reported to positively affect cervical cells in pre-clinical studies and can improve abnormal cervical cells. While evidence suggests these ingredients may independently and in combination improve abnormal cervical cells, investigation of the Papillex® formulation is warranted. Therefore, this study aims to examine the safety and efficacy of Papillex® on abnormal cervical cells.
This study is 180 days with an Option for an Open-Label 6-month Extension
To complete this study, 6 clinic visits and 4 follow-up phone calls are required, along with blood samples, vitals, questionnaires and cervical samples.
You will be required to confirm abnormal pap with cytology results, or if unconfirmed, a pap smear and HPV test will be performed. At the end of the study, a second pap smear, HPV test and colposcopy (where required) will be performed.
To be Eligible for This study You Must be:
- Adult Females, 25-60 years old
- History of CIN-1 diagnosis in the past 18 months
- NOT currently undergoing treatment for CIN, or have not received treatment in the last 5 years
- Do not have any unstable diseases
- No planned surgery during the course of the study.
- Not currently taking Anti-folate medications
With Successful Enrollment and Completion of the Study You will Receive $750 for Your Time.
If interested in participating in this study, sign up below by completing our Eligibility questionnaire
Have any questions about this study?
Please email us
or call us at
